Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. A Machine-learning Assisted Genetic Risk Score Identifies Improved Weight Loss After Endoscopic Sleeve Gastroplasty.
  1. Home
  2. A Machine-learning Assisted Genetic Risk Score Identifies Improved Weight Loss After Endoscopic Sleeve Gastroplasty.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026
Same author

Revisiting POWER in the GLP-1 Age.

Gastroenterology·2026
Same author

Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis.

Obesity (Silver Spring, Md.)·2026
Same author

Endoscopic Sleeve Gastroplasty After Solid Organ Transplantation: First Reported Case Worldwide in a Kidney Transplant Recipient.

ACG case reports journal·2026
Same author

A Subphenotype of Obesity With Reduced Enteroendocrine Glucagon-Like Peptide 1 Synthesis and Enhanced Tirzepatide Response.

Gastroenterology·2026
Same author

Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026
Same journal

Individuals With Food Addiction After Metabolic And Bariatric Surgery Show Higher Consumption of Ultra-Processed Foods, Sedentary Lifestyle, Anxiety, and Sub-Optimal Body Weight Trajectories.

Obesity surgery·2026
Same journal

30-Day Outcomes of Simultaneous Sleeve Gastrectomy and Kidney Transplantation: An Analysis from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database.

Obesity surgery·2026
Same journal

Development and validation of the Maladaptive Eating Behavior Questionnaire after Metabolic and Bariatric Surgery.

Obesity surgery·2026
Same journal

Predictors of Gastroesophageal Reflux Disease Following Bariatric Surgery Assessed by Ambulatory pH Monitoring.

Obesity surgery·2026
Same journal

National Trends and Outcomes of Metabolic and Bariatric Surgery in Adolescents: Insights from the Israeli National Bariatric Surgery Registry.

Obesity surgery·2026
Same journal

Comparative Outcomes of GLP-1 Therapy vs. Bariatric Surgery in Patients with Cirrhosis.

Obesity surgery·2026
See all related articles

Related Experiment Video

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

A Machine-Learning Assisted Genetic Risk Score Identifies Improved Weight Loss After Endoscopic Sleeve Gastroplasty.

Thomas Fredrick1, Daniel Maselli2, Eric Vargas1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA.

Obesity Surgery
|May 6, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

A machine-learning genetic risk score (GRS) for calories to satiation predicts weight loss after endoscopic sleeve gastroplasty (ESG). Individuals with a low CTS-GRS achieved significantly greater total body weight loss post-ESG.

Keywords:
Bariatric SurgeryEndoscopyGenetic ModelsObesity

More Related Videos

A Murine Model of Vertical Sleeve Gastrectomy
06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Related Experiment Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

A Murine Model of Vertical Sleeve Gastrectomy
06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Area of Science:

  • Genetics and Genomics
  • Obesity Medicine
  • Medical Technology

Background:

  • Obesity is a widespread epidemic with serious health implications.
  • Endoscopic sleeve gastroplasty (ESG) promotes substantial weight loss, but outcomes vary.
  • Previous research developed a machine-learning (ML) genetic risk score (GRS) for calorie intake and satiety, predicting response to anti-obesity drugs.

Purpose of the Study:

  • To assess novel GRSs for emotional hunger and calories to satiation (CTS).
  • To determine the predictive capability of these GRSs for weight loss following ESG.
  • To evaluate the performance of high or low CTS GRS in predicting ESG outcomes.

Main Methods:

  • Forty participants undergoing ESG completed genetic testing using the MyPhenome test.
  • ML-assisted GRSs for high/low CTS and emotional hunger were utilized.
  • Total body weight loss (TBWL) at 12 and 24 months was the primary endpoint, analyzed with LOCF, ANOVA, and Tukey's HSD.

Main Results:

  • The low CTS GRS group exhibited greater TBWL compared to other groups across all time points (3-24 months).
  • At 12 months, the low CTS GRS group showed significant TBWL (21.4%) compared to emotional hunger (13.7%) and high CTS GRS (14.9%) groups.
  • This significant weight loss difference persisted through 24 months.

Conclusions:

  • ML-assisted GRSs are linked to enhanced weight loss after ESG.
  • Identifying patients with a higher likelihood of superior weight loss response can optimize ESG candidate selection.
  • GRS may serve as a valuable tool for personalizing obesity treatment strategies.